Lytix Biopharma ASA (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 8.02
0.00 (0.00%)
Oct 13, 2026, 3:29 PM CET
Lytix Biopharma ASA Market Cap
Lytix Biopharma ASA has a market cap or net worth of 616.74 million as of October 13, 2026. It is the 28,536th most valuable company in the world and the 195th biggest in Norway. Its market cap has increased by 15.54% in one year.
Market Cap
616.74M
Enterprise Value
527.12M
Revenue
n/a
Global Rank
Country Rank
#195 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since June 14, 2021, Lytix Biopharma ASA's market cap has decreased from 720.55M to 616.74M, a decrease of -14.41%. That is a compound annual growth rate of -2.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 616.74M | -8.55% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 3.06B |
| Thor Medical ASA | 1.88B |
| Nykode Therapeutics AS | 1.12B |
| ArcticZymes Technologies ASA | 1.00B |
| Zelluna ASA | 586.76M |
| Oncoinvent ASA | 428.99M |
| SoftOx Solutions AS | 310.13M |
| Arctic Bioscience AS | 71.16M |